IP Library Granted Patent US 8,044,215
Granted Patent B2
US 8,044,215 · App. 12/432,660 · Granted Oct 25, 2011

Methods for the preparation of amphillic nitrogen containing imidazolinium derivative compounds

Assignee: Juvaris BioTherapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,044,215
App. No.
12/432,660
Granted
Oct 25, 2011
Kind
B2
Abstract

The disclosure provides new methods for preparing nitrogen-containing amphiphiles and their use in the preparation of liposomes and other lipid-containing carriers of pharmaceutical substances, including nucleic acids used in gene therapy.

Claims (39)

1. A method for preparing a compound of formula (I):

comprising the step of heating a compound of formula (II) between about 30° C. to about 60° C. in a trihaloalkyl/alcohol solvent, and in the presence of molecular sieves, to produce the compound of formula (I):

wherein:

R and R 1 are each independently a C 11 -C 29 straight-chain aliphatic hydrocarbyl group;

and

Y is a halogen, acetate, succinate or citrate.

2. The method of claim 1 , wherein R and R 1 are each:

Y is chloro.

3. The method of claim 1 , wherein the trihaloalkyl/alcohol solvent is about a 4:1 v/v mixture.

4. The method of claim 3 , wherein the trihaloalkyl solvent is chloroform or bromoform; and the alcohol solvent is methanol, ethanol, propanol, or isopropanol.

5. The method of claim 4 , wherein the trihaloalkyl solvent is chloroform; and the alcohol solvent is methanol.

6. The method of claim 1 , wherein the molecular sieves are 4 Å molecular sieves and is present in about a 1:1 to about a 3:1 w/w ratio of 4 Å molecular sieves/compound of formula (II).

7. The method of claim 6 , wherein the 4 Å molecular sieves is present in about a 1:2 w/w ratio of 4 Å molecular sieves/compound of formula (II).

8. The method of claim 1 , wherein the compound of formula (II) is heated to about 55° C. for about 4 to about 24 hours.

9. The method of claim 1 , further comprising purifying the compound of formula (I) by silica gel chromatography (with silica gel or silica gel pre-packed cartridges) and recrystallization from acetone.

10. The method of claim 1 , wherein the compound of formula (I) has formula (III):

11. A method for preparing a compound of formula (I):

comprising the steps of:

a) protecting the secondary amino groups in the compound of formula (IV) to provide the compound of formula (V):

b) protecting the primary alcohol groups in the compound of formula (V) to provide the compound of formula (VI):

c) deprotecting the compound of formula (VI) to provide the compound of formula (II):

d) heating the compound of formula (II) between about 30° C. to about 60° C. in a trihaloalkyl/alcohol solvent, and in the presence of molecular sieves, to produce the compound of formula (I):

wherein:

R and R 1 are each independently a C 11 -C 29 straight-chain aliphatic hydrocarbyl group;

X′ is di-tert-butyldicarbonate ((BOC) 2 O);

X is tert-butyloxycarbonyl (BOC);

Y is a halogen, acetate, succinate or citrate;

Z in OCOR or OCOR 1 .

12. The method of claim 11 , wherein R and R 1 are each:

Y is chloro.

13. The method of claim 12 , wherein the trihaloalkyl/alcohol solvent is about a 4:1 v/v mixture.

14. The method of claim 13 , wherein the trihaloalkyl solvent is chloroform or bromoform; and the alcohol solvent is methanol, ethanol, propanol, or isopropanol.

15. The method of claim 14 , wherein the trihaloalkyl solvent is chloroform; and the alcohol solvent is methanol.

16. The method of claim 12 , wherein the molecular sieves are 4 Å molecular sieves and is present in about a 1:1 to about a 3:1 w/w ratio of 4 Å molecular sieves/compound of formula (II).

17. The method of claim 16 , wherein the 4 Å molecular sieves is present in about a 1:2 w/w ratio of 4 Å molecular sieves/compound of formula (II).

18. The method of claim 12 , wherein the compound of formula (II) is heated to about 55° C. for about 4 to about 24 hours.

19. The method of claim 12 , further comprising purifying the compound of formula (I) by silica gel chromatography and recrystallization from acetone.

20. The method of claim 12 , wherein the compound of formula (I) has formula (III):

21. The method of claim 1 , wherein R and R 1 are each independently a C 11 -C 29 straight-chain aliphatic hydrocarbyl group.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Oct 6, 2015
From: TRIPLEPOINT CAPITAL LLC
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 036739/0195 →
SECURITY AGREEMENT Recorded Oct 4, 2011
From: JUVARIS BIOTHERAPEUTICS, INC.
To: TRIPLEPOINT CAPITAL LLC
Reel/Frame 027015/0765 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2009
From: YU, CHENG-SEIN; BUSSEY, LEE B.
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 022741/0754 →
Continuity (1)
Related Publication 20100280258A1 · Nov 4, 2010